240 related articles for article (PubMed ID: 37815872)
21. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
Wu X; Ajani JA; Gu J; Chang DW; Tan W; Hildebrandt MA; Huang M; Wang KK; Hawk E
Cancer Prev Res (Phila); 2013 Mar; 6(3):196-205. PubMed ID: 23466817
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA in the pathogenesis and prognosis of esophageal cancer.
Gu J; Wang Y; Wu X
Curr Pharm Des; 2013; 19(7):1292-300. PubMed ID: 23092349
[TBL] [Abstract][Full Text] [Related]
23. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.
Dura P; van Veen EM; Salomon J; te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
Int J Cancer; 2013 Oct; 133(7):1751-5. PubMed ID: 23504527
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer.
Garman KS; Owzar K; Hauser ER; Westfall K; Anderson BR; Souza RF; Diehl AM; Provenzale D; Shaheen NJ
Dig Dis Sci; 2013 Nov; 58(11):3178-88. PubMed ID: 23925817
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.
Drahos J; Schwameis K; Orzolek LD; Hao H; Birner P; Taylor PR; Pfeiffer RM; Schoppmann SF; Cook MB
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):429-37. PubMed ID: 26604271
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers.
Bobryshev YV; Orekhov AN; Chistiakov DA
Curr Pharm Des; 2015; 21(23):3402-16. PubMed ID: 25758856
[TBL] [Abstract][Full Text] [Related]
27. Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus.
Grady WM; Yu M
Dig Dis Sci; 2018 Aug; 63(8):2059-2069. PubMed ID: 29766388
[TBL] [Abstract][Full Text] [Related]
28. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA Expression Signatures During Malignant Progression From Barrett's Esophagus.
Bansal A; Gupta V; Wang K
J Cell Biochem; 2016 Jun; 117(6):1288-95. PubMed ID: 26808728
[TBL] [Abstract][Full Text] [Related]
30. Achalasia and associated esophageal cancer risk: What lessons can we learn from the molecular analysis of Barrett's-associated adenocarcinoma?
Nesteruk K; Spaander MCW; Leeuwenburgh I; Peppelenbosch MP; Fuhler GM
Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188291. PubMed ID: 31059738
[TBL] [Abstract][Full Text] [Related]
31. A Systematic Review of Esophageal MicroRNA Markers for Diagnosis and Monitoring of Barrett's Esophagus.
Mallick R; Patnaik SK; Wani S; Bansal A
Dig Dis Sci; 2016 Apr; 61(4):1039-50. PubMed ID: 26572780
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study.
Revilla-Nuin B; Parrilla P; Lozano JJ; de Haro LF; Ortiz A; Martínez C; Munitiz V; de Angulo DR; Bermejo J; Molina J; Cayuela ML; Yélamos J
Ann Surg; 2013 May; 257(5):886-93. PubMed ID: 23059500
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
34. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
Luo HS; Wu DH
Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic biomarkers in esophageal cancer.
Kaz AM; Grady WM
Cancer Lett; 2014 Jan; 342(2):193-9. PubMed ID: 22406828
[TBL] [Abstract][Full Text] [Related]
36. Epigenetics in the Pathogenesis of Esophageal Adenocarcinoma.
Kailasam A; Mittal SK; Agrawal DK
Clin Transl Sci; 2015 Aug; 8(4):394-402. PubMed ID: 25388215
[TBL] [Abstract][Full Text] [Related]
37. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis.
Zhong X; Huang G; Ma Q; Liao H; Liu C; Pu W; Xu L; Cai Y; Guo X
Medicine (Baltimore); 2019 Jul; 98(27):e16269. PubMed ID: 31277149
[TBL] [Abstract][Full Text] [Related]
38. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus.
Guillem P; Billeret V; Buisine MP; Flejou JF; Lecomte-Houcke M; Degand P; Aubert JP; Triboulet JP; Porchet N
Int J Cancer; 2000 Dec; 88(6):856-61. PubMed ID: 11093805
[TBL] [Abstract][Full Text] [Related]
39. Circulating exosomal miRNAs as potential biomarkers for Barrett's esophagus and esophageal adenocarcinoma.
Lv J; Zhao HP; Dai K; Cheng Y; Zhang J; Guo L
World J Gastroenterol; 2020 Jun; 26(22):2889-2901. PubMed ID: 32587437
[TBL] [Abstract][Full Text] [Related]
40. The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis.
Leidner RS; Ravi L; Leahy P; Chen Y; Bednarchik B; Streppel M; Canto M; Wang JS; Maitra A; Willis J; Markowitz SD; Barnholtz-Sloan J; Adams MD; Chak A; Guda K
Genes Chromosomes Cancer; 2012 May; 51(5):473-9. PubMed ID: 22302717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
